Filing Flows › Zenas BioPharma (ZBIO) › Recalls, complaints & regulation
Zenas BioPharma (ZBIO): clinical trials
Zenas BioPharma (ZBIO) beyond its filings: 6 active clinical trials.
Zenas BioPharma's latest quarter
Zenas BioPharma, Q3 2026: revenue $10.0M, net loss $109M, operating cash flow −$58.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Zenas BioPharma have?
6 active studies on ClinicalTrials.gov, 4 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.